ClinicalTrials.Veeva

Menu

Bispectral Monitoring on Mechanically Ventilated Patients (BIMV)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Not yet enrolling

Conditions

Sedation

Treatments

Other: Non-BIS group
Device: BIS group

Study type

Interventional

Funder types

Other

Identifiers

NCT07219069
HSC-MS-25-0240

Details and patient eligibility

About

The purpose of this study is to determine the difference in the duration of mechanical ventilation, to evaluate the difference in ICU length of stay and to determine the difference in the overall dose of sedation medications between the between participants who were monitored using Bispectral index monitoring (BIS) monitors and those who were not.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to the medical ICU
  • Intubated on mechanical ventilation
  • On sedation medication infusion

Exclusion criteria

  • Patients with a history of chronic opioid use
  • Patients with end-stage liver disease at ICU admission (i.e., International normalized ratio >1.5 and not taking warfarin and/or a total serum bilirubin 1.5 times above normal limits)
  • Pregnant patients
  • Current prisoner
  • Refractory shock: Mean arterial blood pressure below 65 millimeters of mercury(65mmHg) despite maximum doses of 3 pressors. Norepinephrine 70mcg/min; vasopressin 0.03 units/min; epinephrine 35mcg/min; dopamine 20mcg/kg/min and phenylephrine 350mcg/min
  • Inability to complete the required time for follow-up
  • Surgical admission diagnosis
  • Patients with skin conditions precluding BIS monitor sensor adherence
  • Patients on neuromuscular blockade infusion or benzodiazepine infusion

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

BIS group
Experimental group
Treatment:
Device: BIS group
Non-BIS group
Active Comparator group
Treatment:
Other: Non-BIS group

Trial contacts and locations

1

Loading...

Central trial contact

Pascal L Kingah, MD, MPH; Elizabeth Vidales

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems